These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34256405)

  • 1. [Update 2021: COVID-19 from the perspective of infectious diseases specialty].
    Khatamzas E; Kroidl I
    Dtsch Med Wochenschr; 2021 Jul; 146(13-14):904-907. PubMed ID: 34256405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
    Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
    Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
    Kamar N; Abravanel F; Marion O; Couat C; Izopet J; Del Bello A
    N Engl J Med; 2021 Aug; 385(7):661-662. PubMed ID: 34161700
    [No Abstract]   [Full Text] [Related]  

  • 5. The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    Abbasi J
    JAMA; 2021 Nov; 326(18):1781-1782. PubMed ID: 34673883
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
    Schmidt F; Muecksch F; Weisblum Y; Da Silva J; Bednarski E; Cho A; Wang Z; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    N Engl J Med; 2022 Feb; 386(6):599-601. PubMed ID: 35030645
    [No Abstract]   [Full Text] [Related]  

  • 7. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
    Edara VV; Pinsky BA; Suthar MS; Lai L; Davis-Gardner ME; Floyd K; Flowers MW; Wrammert J; Hussaini L; Ciric CR; Bechnak S; Stephens K; Graham BS; Bayat Mokhtari E; Mudvari P; Boritz E; Creanga A; Pegu A; Derrien-Colemyn A; Henry AR; Gagne M; Douek DC; Sahoo MK; Sibai M; Solis D; Webby RJ; Jeevan T; Fabrizio TP
    N Engl J Med; 2021 Aug; 385(7):664-666. PubMed ID: 34233096
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
    Lu L; Zhang H; Zhan M; Jiang J; Yin H; Dauphars DJ; Li SY; Li Y; He YW
    Sci China Life Sci; 2020 Dec; 63(12):1833-1849. PubMed ID: 33355886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
    Frieman M; Harris AD; Herati RS; Krammer F; Mantovani A; Rescigno M; Sajadi MM; Simon V
    EBioMedicine; 2021 Jun; 68():103401. PubMed ID: 34051441
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera.
    Miyakawa K; Jeremiah SS; Kato H; Yamaoka Y; Go H; Yajima S; Shimada T; Mihara T; Goto A; Yamanaka T; Ryo A
    J Mol Cell Biol; 2022 Jan; 13(12):918-920. PubMed ID: 34450642
    [No Abstract]   [Full Text] [Related]  

  • 11. Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands.
    Tang MS; Farnsworth CW
    Clin Chem; 2021 Apr; 67(5):707-709. PubMed ID: 33772260
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: "Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2" by Krsak
    Mishra BK; Bhattacharya D; Kshatri JS; Pati S
    Viral Immunol; 2021 Nov; 34(9):658. PubMed ID: 34672807
    [No Abstract]   [Full Text] [Related]  

  • 13. Audio Interview: How Well Are Covid-19 Vaccines Working?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jul; 385(2):e15. PubMed ID: 34233102
    [No Abstract]   [Full Text] [Related]  

  • 14. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
    Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A
    Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines may cause rare, Long Covid-like symptoms.
    Couzin-Frankel J; Vogel G
    Science; 2022 Jan; 375(6579):364-366. PubMed ID: 35084966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding protection from SARS-CoV-2 by studying reinfection.
    Overbaugh J
    Nat Med; 2020 Nov; 26(11):1680-1681. PubMed ID: 33093682
    [No Abstract]   [Full Text] [Related]  

  • 17. Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine.
    Banga Ndzouboukou JL; Zhang YD; Lei Q; Lin XS; Yao ZJ; Fu H; Yuan LY; Fan XL
    Curr Med Sci; 2021 Dec; 41(6):1081-1086. PubMed ID: 34741251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long road.
    Cohen J
    Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
    [No Abstract]   [Full Text] [Related]  

  • 19. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
    Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
    BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 vaccine candidates in rapid development.
    Li L; Guo P; Zhang X; Yu Z; Zhang W; Sun H
    Hum Vaccin Immunother; 2021 Mar; 17(3):644-653. PubMed ID: 33121319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.